| Dr Tonyatta T Hairston, OD | |
|
3136 North State Street, Jackson, MS 39202 | |
| (601) 987-3937 | |
| (601) 987-3922 |
| Full Name | Dr Tonyatta T Hairston |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 23 Years |
| Location | 3136 North State Street, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295847432 | NPI | - | NPPES |
| 04771528 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 658 (Mississippi) | Primary |
| Provider Name | Envision Eye Care, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1083734867 PECOS PAC ID: 5496722936 Enrollment ID: O20040914000445 |
News Archive
In other state Medicaid news, doctors in Washington state are suing to stop a new rule that limits enrollees' visits to the emergency department and Gov. Cuomo's administration dismisses a proposal for N.Y. to pay for transgender surgery.
Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.
The administration even filed its legal briefs early -; one outlining its defense of the measure's constitutionality in response to the 26-state challenge, the other responding to Liberty University's challenge. Meanwhile, the 8th Circuit Court of Appeals is scheduled to hear arguments Thursday in Missouri's official challenge.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the commencement of a Phase 2 clinical trial of GMI-1070 for treatment of vaso-occlusive crisis of sickle cell disease. The company also announced that GMI-1070 has received Fast Track designation from the U.S. Food and Drug Administration.
A new study of the burden of cholera in three impoverished regions of the world, published February 20 in the open-access journal PLoS Neglected Tropical Diseases, found that young children bear the brunt of the disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tonyatta T Hairston, OD 1316 North State Street, Jackson, MS 39202 Ph: (601) 987-3937 | Dr Tonyatta T Hairston, OD 3136 North State Street, Jackson, MS 39202 Ph: (601) 987-3937 |
News Archive
In other state Medicaid news, doctors in Washington state are suing to stop a new rule that limits enrollees' visits to the emergency department and Gov. Cuomo's administration dismisses a proposal for N.Y. to pay for transgender surgery.
Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.
The administration even filed its legal briefs early -; one outlining its defense of the measure's constitutionality in response to the 26-state challenge, the other responding to Liberty University's challenge. Meanwhile, the 8th Circuit Court of Appeals is scheduled to hear arguments Thursday in Missouri's official challenge.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the commencement of a Phase 2 clinical trial of GMI-1070 for treatment of vaso-occlusive crisis of sickle cell disease. The company also announced that GMI-1070 has received Fast Track designation from the U.S. Food and Drug Administration.
A new study of the burden of cholera in three impoverished regions of the world, published February 20 in the open-access journal PLoS Neglected Tropical Diseases, found that young children bear the brunt of the disease.
› Verified 7 days ago
Envision Eye Care, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 1316 North State Street, Jackson, MS 39202 Phone: 601-987-3937 Fax: 601-987-3922 | |
Medical Mall Vision Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 350 West Woodrow Wilson Ave, Suite 3110, Jackson, MS 39213 Phone: 601-366-9020 Fax: 601-321-3979 | |
Dr. Allen Dixon Findley, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2711 Greenway Dr, Suite A, Jackson, MS 39204 Phone: 601-922-9300 Fax: 601-922-6312 | |
Findley Vision, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2711 Greenway Dr, Jackson, MS 39204 Phone: 601-922-9300 Fax: 601-922-6312 | |
Dellia Salone Evans, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1461 Canton Mart Rd Ste A, Jackson, MS 39211 Phone: 601-977-0835 Fax: 601-977-0689 | |
R. Kirk Smithhart, O.d. Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 500k E Woodrow Wilson Ave, Jackson, MS 39216 Phone: 601-366-4221 Fax: 601-362-3153 | |
Odoms Eye Care/optical Optometrist Medicare: Medicare Enrolled Practice Location: 1461 Canton Mart Rd Ste A, Jackson, MS 39211 Phone: 601-977-0835 Fax: 601-977-0689 |